Could Vitamin D Reduce Obesity-associated Inflammation? Observational and Mendelian Randomization Study
Overview
Authors
Affiliations
Background: Obesity is associated with inflammation but the role of vitamin D in this process is not clear.
Objectives: We aimed to assess the associations between serum 25-hydroxyvitamin D [25(OH)D], BMI, and 16 inflammatory biomarkers, and to assess the role of vitamin D as a potential mediator in the association between higher BMI and inflammation.
Methods: Northern Finland Birth Cohort 1966 (NFBC1966) 31-y data on 3586 individuals were analyzed to examine the observational associations between BMI, 25(OH)D, and 16 inflammatory biomarkers. Multivariable regression analyses and 2-sample regression-based Mendelian randomization (MR) mediation analysis were performed to assess any role of vitamin D in mediating a causal effect of BMI on inflammatory biomarkers [soluble intercellular adhesion molecule 1 (sICAM-1), high sensitivity C-reactive protein (hs-CRP), and α1-acid glycoprotein (AGP)] for which observational associations were detected. For MR, genome-wide association study summary results ranging from 5163 to 806,834 individuals were used for biomarkers, 25(OH)D, and BMI. Findings were triangulated with a literature review of vitamin D supplementation trials.
Results: In NFBC1966, mean BMI (kg/m2) was 24.8 (95% CI: 24.7, 25.0) and mean 25(OH)D was 50.3 nmol/L (95% CI: 49.8, 50.7 nmol/L). Inflammatory biomarkers correlated as 4 independent clusters: interleukins, adhesion molecules, acute-phase proteins, and chemokines. BMI was positively associated with 9 inflammatory biomarkers and inversely with 25(OH)D (false discovery rate < 0.05). 25(OH)D was inversely associated with sICAM-1, hs-CRP, and AGP, which were positively associated with BMI. The MR analyses showed causal association of BMI on these 3 inflammatory biomarkers. There was no observational or MR evidence that circulating 25(OH)D concentrations mediated the association between BMI and these 3 inflammatory markers. Review of randomized controlled trials (RCTs) supported our findings showing no impact of vitamin D supplementation on inflammatory biomarkers.
Conclusions: The findings from our observational study and causal MR analyses, together with data from RCTs, do not support a beneficial role of vitamin D supplementation on obesity-related inflammation.
Cartes-Velasquez R, Vera A, Torres-Quevedo R, Medrano-Diaz J, Perez A, Munoz C Nutrients. 2024; 16(23).
PMID: 39683528 PMC: 11643987. DOI: 10.3390/nu16234134.
The Effect of Vitamin D Supplementation with or without Calcium on Vitamin D Epimer and Metabolites.
Gariballa S, Al-Bluwi G, Yasin J Metabolites. 2024; 14(10).
PMID: 39452905 PMC: 11509787. DOI: 10.3390/metabo14100524.
Hertis Petek T, Homsak E, Svetej M, Marcun Varda N Int J Mol Sci. 2024; 25(19).
PMID: 39408928 PMC: 11476559. DOI: 10.3390/ijms251910599.
Wolters M, Foraita R, Moreno L, Molnar D, Russo P, Tornaritis M Eur J Nutr. 2024; 63(8):3047-3060.
PMID: 39231874 PMC: 11519216. DOI: 10.1007/s00394-024-03488-7.
Roth B, Ohlsson B BMC Gastroenterol. 2024; 24(1):296.
PMID: 39227769 PMC: 11370284. DOI: 10.1186/s12876-024-03373-x.